Stocktoria
Entrada Therapeutics, Inc. TRDA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-10-29
Entrada Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 1,693,867 | $24.1M | 4.09% |
| MILLENNIUM MANAGEMENT LLC | 519,356 | $6.6M | 1.26% |
| CITADEL ADVISORS LLC | 215,018 | $2.7M | 0.52% |
| RENAISSANCE TECHNOLOGIES LLC | 202,084 | $2.6M | 0.49% |
| AQR CAPITAL MANAGEMENT LLC | 79,493 | $1.0M | 0.19% |
| D. E. Shaw & Co., Inc. | 79,047 | $997,573 | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 44,602 | $562,877 | 0.11% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.